Crimean-Congo hemorrhagic fever: An update

Area of Science:

• Virology
• Epidemiology
• Infectious Diseases

Background:

• Crimean-Congo hemorrhagic fever (CCHF) is a severe viral hemorrhagic fever caused by a Nairovirus.
• Amplifying hosts include asymptomatic mammals, with human infection via tick bites or animal blood contact.
• CCHF is endemic across Africa, Asia, and Southeast Europe, with recent cases in Spain indicating geographic expansion.

Purpose of the Study:

• To summarize the key aspects of Crimean-Congo hemorrhagic fever.
• To highlight diagnostic methods and current treatment strategies.
• To emphasize the importance of preventative measures against CCHF.

Main Methods:

• Review of CCHF characteristics, including transmission, symptoms, and geographic distribution.
• Description of diagnostic techniques: PCR for early detection and serology for later stages.
• Discussion of patient management and the role of ribavirin.

Main Results:

• Initial symptoms mimic other infectious diseases, progressing to hemorrhagic syndrome.
• Diagnosis is confirmed by PCR and IgM antibody testing.
• Supportive care is the mainstay of treatment, with ribavirin use debated but recommended by WHO post-exposure.

Conclusions:

• CCHF presents with diverse symptoms and requires strict isolation to prevent nosocomial spread.
• Effective diagnosis relies on timely PCR and serological testing.
• While supportive care is primary, ribavirin is considered for post-exposure prophylaxis in healthcare professionals.